Emmanuel Valjent
  • E-mail :[email]
  • Phone : +33 4 34 35 92 22
  • Location : Montpellier, France
Last update 2020-01-23 18:31:05.035

Emmanuel Valjent PhD Neuroscience

Course and current status

Short CV of the Team leader

Education / Training

1992    Baccalaureate (Biology)

1997    Master in Cell Biology and Physiology (University Paris VI)

1998    DEA in Neurosciences (University Paris VI)

2001    PhD in Neurosciences (University Paris VI and University Pompeu Fabra, Barcelona)

2014    “Habilitation à diriger des recherches” (HDR), Montpellier I University

Positions Held

2018-present: Group Leader, research Director 2nd class 

2015-present    Group Leader,  Research Associate 1st class,

Inserm U1191, CNRS UMR5203, Univ Montpellier, Institute of Functional Genomic (IGF), Montpellier, France.

2009-2014       Group Leader “ATIP-Avenir Team”, Research Associate 1st class,

Inserm U661, CNRS UMR5203, Univ Montpellier I & II, Institute of Functional Genomic (IGF), Montpellier, France.

2007-2010       Visiting Scientist, Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden.

2005-2009       Research Associate 2nd class, Inserm U536 and U839, Institute du Fer à Moulin, Paris, France. (with Jean-Antoine Girault, M.D., Ph.D.)

2001-2004       Post-Doctoral Fellow, Inserm U536 (with Jean-Antoine Girault, M.D., Ph.D.)

1998-2001       Graduate Student, Department of Neuropsychopharmacology, Univ Pompeu Fabra, Barcelona, Spain (with Pr. Rafael. Maldonado, M.D, Ph.D.) and CNRS, Univ Paris VI, Paris, France (with Jocelyne Caboche, Ph.D.).

1997-1998       Pregraduate Student, Inserm U266 (Pr. B.P. Roques)

Honors and Fellowships

ATIP-Avenir Award 2009-2014

Swedish Research Council Fellowship 2008-2010

Fondation pour la Recherche Medicale (FRM) Student Fellowship 2001

Fondation des Treilles Student Fellowship 1999-2000

Professional Affiliations

American Society for Neuroscience

French Society for Neuroscience

Publications (94 publications in Pubmed, h=42)

Scientific summary

Selection and execution of appropriate behavioral responses rely on the ability to properly use sensory information to predict future rewards or punishments. The dorsal striatum and the nucleus accumbens are two major structures critically involved in this learning process. We put forward that the regulation of local mRNA translation control, resulting from the integration of glutamate-mediated sensory information and dopamine-mediated reward signals, could be an important process that elicits the neuronal plasticity required for striatal-dependent learning. The general objective of our research aims to characterize the molecular mechanisms involved mRNA translational control resulting from the integration of dopamine and glutamate signals and to understand the functional impact of such events on dopamine-controlled learning and pathology. Beyond its implication in basic science, our project may also provides important information for the development of new therapeutic strategies in neurological and psychiatric disorders related to striatal dysfunction such as Parkinson’s disease, obsessive-compulsive disorder and drug addiction.

Image d’exemple